EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The microenvironment in atherosclerosis: molecular regulation mechanism and immunotherapy

Xiaoyu Teng, Qinlian Jiao, Yidan Ren, Xin Su, Zigan Li, Yuxuan Cai, Tangbin Hu, Maoxiao Feng, Xiaoyan Liu, Ming Xia, Jun Tai, Yana Zhang und 2 weitere

Engineered Regeneration · 2025 · 6 · 174-187

DOI: 10.1016/j.engreg.2025.07.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Engineered Regeneration, 2025. Verfasst von Xiaoyu Teng und 13 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shandong Province Natural Science Foundation, State Administration of Traditional Chinese Medicine of The Peoples Republic of China, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a chronic inflammatory disease closely linked to immune dysregulation. The immune microenvironment within atherosclerotic lesions is highly complex, involving diverse innate and adaptive immune cells and their intricate crosstalk. These immune interactions collectively contribute to plaque formation, progression, and destabilization. This review comprehensively examines the roles of key immune cell populations—including macrophages, dendritic cells (DCs), neutrophils, mast cells, natural killer (NK) cells, T cells, and B cells—in regulating inflammation, foam cell formation, and lesion stability. Special attention is given to intercellular regulatory circuits such as the Th1–M1 feedback loop, the OX40L–Th17 axis, and DC–T–NK amplification loops. Furthermore, the review highlights the influence of immunometabolic reprogramming on immune cell function and plaque phenotype, illustrating how metabolic states shape inflammatory outcomes. It also discusses the contribution of key signaling pathways—including Toll-like receptors (TLRs), the NOD-like receptor protein 3 (NLRP3) inflammasome, and proprotein convertase subtilisin/kexin type 9 (PCSK9)—to atherosclerotic inflammation and plaque vulnerability. Advances in immunotherapy are also reviewed, including anti-inflammatory agents such as colchicine and canakinumab, as well as emerging vaccine strategies targeting lipid metabolism and vascular inflammation. A deeper understanding of immune cell interplay and signaling dynamics in atherosclerosis will provide a foundation for developing more effective, multi-targeted immunotherapeutic interventions. Future research should aim to refine these strategies to maximize efficacy and safety, with the goal of reducing the global burden of atherosclerotic cardiovascular disease.

Förderung

  • Shandong Province Natural Science Foundation
  • State Administration of Traditional Chinese Medicine of The Peoples Republic of China
  • National Natural Science Foundation of China

Zitieren

APA

Teng, X., Jiao, Q., Ren, Y., Su, X., Li, Z., Cai, Y., Hu, T., Feng, M., Liu, X., Xia, M., Tai, J., Zhang, Y., Wang, Y., & Wang, M. (2025). The microenvironment in atherosclerosis: molecular regulation mechanism and immunotherapy. Engineered Regeneration, 6, 174-187. https://doi.org/10.1016/j.engreg.2025.07.002

Vancouver

Teng X, Jiao Q, Ren Y, Su X, Li Z, Cai Y, et al. The microenvironment in atherosclerosis: molecular regulation mechanism and immunotherapy. Engineered Regeneration. 2025;6:174-187. doi:10.1016/j.engreg.2025.07.002

BibTeX
@article{Teng2025,
  author = {Teng, Xiaoyu and Jiao, Qinlian and Ren, Yidan and Su, Xin and Li, Zigan and Cai, Yuxuan and Hu, Tangbin and Feng, Maoxiao and Liu, Xiaoyan and Xia, Ming and Tai, Jun and Zhang, Yana and Wang, Yunshan and Wang, Mo},
  title = {The microenvironment in atherosclerosis: molecular regulation mechanism and immunotherapy},
  journal = {Engineered Regeneration},
  year = {2025},
  volume = {6},
  pages = {174--187},
  doi = {10.1016/j.engreg.2025.07.002}
}
Kostenlos starten →